- Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry. Seminars in Arthritis and Rheumatism. 2015 In Process GET IT
- Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial. Arthritis research & therapy. 2015 In Process GET IT
- Submaximal heart and pulmonary evaluation: a novel noninvasive test to identify pulmonary hypertension in patients with systemic sclerosis. Arthritis care & research. 2013 Academic Article GET IT
Low prevalence of coeliac disease in patients with systemic sclerosis: a cross-sectional study of a registry cohort.
Rheumatology (Oxford, England).
Times cited: 1
Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial.
Annals of the rheumatic diseases.
Times cited: 66
Overlap between systemic lupus erythematosus and Kikuchi Fujimoto disease: a clinical pathology conference held by the Department of Rheumatology at Hospital for Special Surgery.
HSS journal : the musculoskeletal journal of Hospital for Special Surgery.
Times cited: 7